Angela N Phan

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.

Frontiers in Psychiatry 2023 Angela N Phan, Garth E Terry 6 citations

Cannabis use disorder (CUD) is prevalent in ~2-5% of adults in the United States and is anticipated to increase as restrictions to cannabis decrease and tetrahydrocannabinol (THC) content in cannabis products increase. No FDA-approved medications for CUD are currently available, despite trials of dozens of re-purposed and novel drugs. Psychedelics have garnered interest as a therapeutic class...